Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02073331 · ClinicalTrials.gov registry record

Obtain Additional Information on Use of CorMatrix ECM (Extracellular Matrix)

A clinical trial, sponsored by Elutia.

Completed
Registry status
1,420
Enrollment target

NCT02073331: Completed study, sponsored by Elutia.

NCT02073331 is a clinical trial that has completed, run by Elutia. The registered enrollment target is 1,420 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02073331 has completed, sponsored by Elutia.

COMPLETED
Registry status
1,420 participants
Enrollment target

Study Summary

The objective of the study is to actively gather additional information on the use of CorMatrix ECM for pericardial reconstruction.

Primary Outcome

Data will be collected at the initial post-operative visit. This is a single visit study.

Trial Details

FieldValue
Enrollment Target 1,420 participants
Start Date 2014-03
Est. Completion 2017-12
Elutia

10 total trials

What the finished NCT02073331 record still lists

NCT02073331 is an observational study that tracks outcomes without assigning an intervention. Its 1,420 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT02073331 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02073331 about?

NCT02073331 is a clinical study titled "Obtain Additional Information on Use of CorMatrix ECM (Extracellular Matrix)". The objective of the study is to actively gather additional information on the use of CorMatrix ECM for pericardial reconstruction.

What is the current status of trial NCT02073331?

This trial is currently completed. The enrollment target is 1,420 participants. The study started on 2014-03. Estimated completion is 2017-12.

Who is sponsoring clinical trial NCT02073331?

This trial is sponsored by Elutia, which has 10 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05890404 · 1,410 participants · NA

    SGM Evidenced-Based Mental Healthcare Implementation

  • NCT07042451 · 1,410 participants · NA

    An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support

  • NCT07222566 · 1,410 participants · Phase 3

    A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • NCT05992935 · 1,405 participants · Phase 1

    Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02073331, the US trial registry maintained by the National Library of Medicine. NCT02073331 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.